 Objective: A prospective randomized controlled trial will be conducted to evaluate the effect of low dose of tibolone and estradioldrospirenone on the histology, expression of estrogen ER and progesterone receptors PR and Bcl-2 protein, in endometrium of postmenopausal women. 